- Home
- BMBL vs EBS Comparison
BMBL vs EBS Comparison
Compare BMBL & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMBL
- EBS
- Stock Information
- Founded
- BMBL 2014
- EBS 1998
- Country
- BMBL United States
- EBS United States
- Employees
- BMBL N/A
- EBS N/A
- Industry
- BMBL Computer Software: Prepackaged Software
- EBS Biotechnology: Pharmaceutical Preparations
- Sector
- BMBL Technology
- EBS Health Care
- Exchange
- BMBL Nasdaq
- EBS Nasdaq
- Market Cap
- BMBL 446.5M
- EBS 393.9M
- IPO Year
- BMBL 2021
- EBS 2006
- Fundamental
- Price
- BMBL $5.74
- EBS $6.29
- Analyst Decision
- BMBL Hold
- EBS Strong Buy
- Analyst Count
- BMBL 15
- EBS 3
- Target Price
- BMBL $6.56
- EBS $14.33
- AVG Volume (30 Days)
- BMBL 3.5M
- EBS 1.4M
- Earning Date
- BMBL 05-07-2025
- EBS 05-07-2025
- Dividend Yield
- BMBL N/A
- EBS N/A
- EPS Growth
- BMBL N/A
- EBS N/A
- EPS
- BMBL N/A
- EBS N/A
- Revenue
- BMBL $1,050,969,000.00
- EBS $965,400,000.00
- Revenue This Year
- BMBL N/A
- EBS N/A
- Revenue Next Year
- BMBL N/A
- EBS $16.07
- P/E Ratio
- BMBL N/A
- EBS N/A
- Revenue Growth
- BMBL N/A
- EBS N/A
- 52 Week Low
- BMBL $3.55
- EBS $4.02
- 52 Week High
- BMBL $12.03
- EBS $15.10
- Technical
- Relative Strength Index (RSI)
- BMBL 57.60
- EBS 55.26
- Support Level
- BMBL $5.67
- EBS $6.17
- Resistance Level
- BMBL $6.26
- EBS $6.68
- Average True Range (ATR)
- BMBL 0.25
- EBS 0.37
- MACD
- BMBL -0.03
- EBS -0.01
- Stochastic Oscillator
- BMBL 25.71
- EBS 57.31
About BMBL Bumble Inc.
Bumble Inc is engaged in offering online dating services. The platform enables people to connect and build healthy and equitable relationships on their own terms. The company operates two apps, Bumble and Badoo, where users come every month to discover new people and connect. The company Operates in USA and also Internationally such as United Kingdom, Czech Republic, and others with maximum of revenue from Other Countries.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.